Colon Cancer

<< Back

Headlines:

• Study Supports CT-Based 'Virtual' Colonoscopy to Spot Colon Cancer
  HealthDay via Yahoo! News Thu, 23 Feb 2012 16:09 PM PST THURSDAY, Feb. 23 (HealthDay News) -- Noninvasive, CT-guided "virtual" colonoscopy is similar to standard colonoscopy in its ability to detect colorectal cancer and precancerous polyps in people 65 and older, a new study finds.
• UK'S NICE Turns Down Cancer Drugs From Merck, Roche, Amgen
  Nasdaq Tue, 24 Jan 2012 16:21 PM PST
  The U.K.'s health-care cost-effectiveness regulator Wednesday turned down three oncology medicines for use in treating colorectal cancer that has spread to other parts of the body--Merck KGaA's (MRK.XE) Erbitux, Roche Holding AG's (ROG.VX) Avastin and Amgen Inc.'s (AMGN) Vectibix.
• More Evidence for Oxaliplatin as Colon Cancer Chemotherapy
  HealthDay via Yahoo! News Fri, 20 Jan 2012 16:10 PM PST
  Adding oxaliplatin to a standard chemotherapy regimen boosts survival rates for patients with advanced colon cancer, according to a new study that bolsters previous research on the drug by looking at a broader group of patients.
• Gene Mutation Linked to Chemo-Resistant Colon Cancer: Finding could help identify which patients would benefit from specific chemotherapy, researchers say
  By Steven Reinberg HealthDay Reporter WEDNESDAY, Jan. 4 (HealthDay News)
  Some people with advanced colorectal cancer are resistant to some types of chemotherapy, and a mutation in the so-called TFAP2E gene may play a part in that resistance, German researchers report.